8-OH-DPAT
From Wikipedia, the free encyclopedia
|
8-OH-DPAT
|
|
| Systematic (IUPAC) name | |
| 8-Hydroxy-2-(di-n-propylamino)tetralin | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C16H25NO |
| Mol. mass | 247.38 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tertraline) is a substance which acts as an agonist of the 5HT1A and 5HT7 receptors.[1]
It can elicit pelvic floor contractions [2].
[edit] References
- ^ S. Schuhler, M. Saboureau, B. Pitrosky and P. Pévet (October 1998). "In Syrian hamsters, 5-HT fibres within the suprachiasmatic nuclei are necessary for the expression of 8-OH-DPAT induced phase-advance of locomotor activity rhythm". Neuroscience Letters 256 (1): 33–36. doi:.
- ^ Thomas et al., (2007)

